These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 11146723

  • 1. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement.
    Handwerger BA, Blodi BA, Chandra SR, Olsen TW, Stevens TS.
    Arch Ophthalmol; 2001 Jan; 119(1):28-32. PubMed ID: 11146723
    [Abstract] [Full Text] [Related]

  • 2. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
    Hassan AS, Johnson MW, Schneiderman TE, Regillo CD, Tornambe PE, Poliner LS, Blodi BA, Elner SG.
    Ophthalmology; 1999 Oct; 106(10):1900-6; discussion 1906-7. PubMed ID: 10519583
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
    Kung YH, Wu TT, Hong MC, Sheu SJ.
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):469-74. PubMed ID: 20925578
    [Abstract] [Full Text] [Related]

  • 4. Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions.
    Hattenbach LO, Klais C, Koch FH, Gümbel HO.
    Ophthalmology; 2001 Aug; 108(8):1485-92. PubMed ID: 11470706
    [Abstract] [Full Text] [Related]

  • 5. Pneumatic displacement of a dense submacular hemorrhage with or without tissue plasminogen activator.
    Yang PM, Kuo HK, Kao ML, Chen YJ, Tsai HH.
    Chang Gung Med J; 2005 Dec; 28(12):852-9. PubMed ID: 16515019
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.
    Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC.
    Ophthalmology; 2004 Jun; 111(6):1201-8. PubMed ID: 15177972
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intravitreal tissue plasminogen activator, perfluoropropane (C3F8), and ranibizumab or photodynamic therapy for submacular hemorrhage secondary to wet age-related macular degeneration.
    Papavasileiou E, Steel DH, Liazos E, McHugh D, Jackson TL.
    Retina; 2013 Apr; 33(4):846-53. PubMed ID: 23400079
    [Abstract] [Full Text] [Related]

  • 11. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC.
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [Abstract] [Full Text] [Related]

  • 12. Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas.
    Chen CY, Hooper C, Chiu D, Chamberlain M, Karia N, Heriot WJ.
    Retina; 2007 Mar; 27(3):321-8. PubMed ID: 17460587
    [Abstract] [Full Text] [Related]

  • 13. Results of intravitreal tissue plasminogen activator and expansile gas injection for submacular haemorrhage in Thais.
    Ratanasukon M, Kittantong A.
    Eye (Lond); 2005 Dec; 19(12):1328-32. PubMed ID: 15565185
    [Abstract] [Full Text] [Related]

  • 14. Management of submacular hemorrhage with intravitreal sulfur hexafluoride: a pilot study.
    Daneshvar H, Kertes PJ, Leonard BC, Peyman GA.
    Can J Ophthalmol; 1999 Dec; 34(7):385-8. PubMed ID: 10649579
    [Abstract] [Full Text] [Related]

  • 15. Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injection for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy.
    Kitagawa Y, Shimada H, Mori R, Tanaka K, Yuzawa M.
    Ophthalmology; 2016 Jun; 123(6):1278-86. PubMed ID: 26949121
    [Abstract] [Full Text] [Related]

  • 16. Pneumatic displacement of submacular hemorrhage with or without tissue plasminogen activator.
    Mizutani T, Yasukawa T, Ito Y, Takase A, Hirano Y, Yoshida M, Ogura Y.
    Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1153-7. PubMed ID: 21445629
    [Abstract] [Full Text] [Related]

  • 17. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage secondary to retinal artery macroaneurysm.
    Wu TT, Sheu SJ.
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):62-7. PubMed ID: 15718829
    [Abstract] [Full Text] [Related]

  • 18. Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD.
    Hay SR, Madonna RJ.
    Optometry; 2000 Nov; 71(11):715-21. PubMed ID: 11101129
    [Abstract] [Full Text] [Related]

  • 19. Pneumatic displacement of acute submacular hemorrhage with and without the use of tissue plasminogen activator.
    Cakir M, Cekiç O, Yilmaz OF.
    Eur J Ophthalmol; 2010 Nov; 20(3):565-71. PubMed ID: 20037915
    [Abstract] [Full Text] [Related]

  • 20. Management of Acute Submacular Hemorrhage with Intravitreal Injection of Tenecteplase, Anti-vascular Endothelial Growth Factor and Gas.
    Lee JP, Park JS, Kwon OW, You YS, Kim SH.
    Korean J Ophthalmol; 2016 Jun; 30(3):192-7. PubMed ID: 27247518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.